These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9688051)

  • 1. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    Pharm Res; 1998 Jul; 15(7):1001-6. PubMed ID: 9688051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
    J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites.
    Neuhoff S; Langguth P; Dressler C; Andersson TB; Regårdh CG; Spahn-Langguth H
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):168-79. PubMed ID: 10783826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L; Murphy GF; Béliveau R
    Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier.
    Matsuzaki J; Yamamoto C; Miyama T; Takanaga H; Matsuo H; Ishizuka H; Kawahara Y; Kuwano M; Naito M; Tsuruo T; Sawada Y
    Biopharm Drug Dispos; 1999 Mar; 20(2):85-90. PubMed ID: 10206323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats.
    Hanafy A; Langguth P; Spahn-Langguth H
    Eur J Pharm Sci; 2001 Feb; 12(4):405-15. PubMed ID: 11231107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.
    Gao J; Murase O; Schowen RL; Aubé J; Borchardt RT
    Pharm Res; 2001 Feb; 18(2):171-6. PubMed ID: 11405287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.
    Ogihara T; Kamiya M; Ozawa M; Fujita T; Yamamoto A; Yamashita S; Ohnishi S; Isomura Y
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
    Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.
    Parasrampuria DA; Lantz MV; Benet LZ
    Pharm Res; 2001 Jan; 18(1):39-44. PubMed ID: 11336351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
    Pajeva IK; Wiese M
    J Med Chem; 2002 Dec; 45(26):5671-86. PubMed ID: 12477351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
    Takanaga H; Ohnishi A; Matsuo H; Sawada Y
    Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
    Nakayama A; Saitoh H; Oda M; Takada M; Aungst BJ
    Eur J Pharm Sci; 2000 Oct; 11(4):317-24. PubMed ID: 11033075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel bisacridone and comparison with PSC 833 as a potent and poorly reversible modulator of P-glycoprotein.
    Horton JK; Thimmaiah KN; Altenberg GA; Castro AF; Germain GS; Gowda GK; Houghton PJ
    Mol Pharmacol; 1997 Dec; 52(6):948-57. PubMed ID: 9415704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells.
    Candussio L; Crivellato E; Rosati AM; Klugmann FB; Granzotto M; Giraldi T; Decorti G
    Histochem J; 2001 May; 33(5):259-66. PubMed ID: 11563538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.
    Declèves X; Chappey O; Boval B; Niel E; Scherrmann JM
    Pharm Res; 1998 May; 15(5):712-8. PubMed ID: 9619779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.
    Martin C; Higgins CF; Callaghan R
    Biochemistry; 2001 Dec; 40(51):15733-42. PubMed ID: 11747450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.